UBS Group’s Rani Therapeutics RANI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9K | Sell |
62,064
-10,053
| -14% | -$5.17K | ﹤0.01% | 6813 |
|
|
2025
Q1 | $90.9K | Buy |
72,117
+48,592
| +207% | +$61.2K | ﹤0.01% | 5845 |
|
|
2024
Q4 | $32.2K | Buy |
23,525
+7,816
| +50% | +$10.7K | ﹤0.01% | 6330 |
|
|
2024
Q3 | $33.9K | Buy |
15,709
+12,709
| +424% | +$27.5K | ﹤0.01% | 5860 |
|
|
2024
Q2 | $11.4K | Hold |
3,000
| – | – | ﹤0.01% | 6489 |
|
|
2024
Q1 | $9.33K | Buy |
+3,000
| New | +$9.33K | ﹤0.01% | 6117 |
|
|
2023
Q4 | – | Sell |
-5,700
| Closed | -$12.4K | – | 8465 |
|
|
2023
Q3 | $12.4K | Buy |
5,700
+1,688
| +42% | +$3.67K | ﹤0.01% | 5884 |
|
|
2023
Q2 | $16.5K | Buy |
4,012
+3,012
| +301% | +$12.4K | ﹤0.01% | 5884 |
|
|
2023
Q1 | $5.16K | Hold |
1,000
| – | – | ﹤0.01% | 6977 |
|
|
2022
Q4 | $5.9K | Hold |
1,000
| – | – | ﹤0.01% | 7922 |
|
|
2022
Q3 | $10K | Sell |
1,000
-1,538
| -61% | -$15.4K | ﹤0.01% | 7348 |
|
|
2022
Q2 | $26K | Sell |
2,538
-1,032
| -29% | -$10.6K | ﹤0.01% | 5532 |
|
|
2022
Q1 | $48K | Sell |
3,570
-1,621
| -31% | -$21.8K | ﹤0.01% | 5514 |
|
|
2021
Q4 | $85K | Buy |
5,191
+2,121
| +69% | +$34.7K | ﹤0.01% | 5381 |
|
|
2021
Q3 | $55K | Buy |
+3,070
| New | +$55K | ﹤0.01% | 5169 |
|